-
The Nigerian fishing community being eaten up by the Atlantic
-
Trump says US scaling back military drills with Seoul hours before start
-
Kushner to meet Netanyahu after talks with Hamas on Gaza plan
-
Nearly 13,000 displaced after deadly Indonesian quake
-
Photos, memories all that remain for Colombia's bereaved after quake
-
Axe hangs over Australian batters after Darwin 'disaster'
-
Sabalenka squeezes out win on sixth match point in Cincinnati
-
Is this cave in Turkey where Homer wrote 'The Odyssey'?
-
Trump says US scaling back military drills with South Korea hours before start
-
Winning back walls from gangs, artists fill El Salvador's towns with color
-
Jason Arday: UK academic who died amid plagiarism storm
-
Opening arguments expected in Tupac murder trial
-
Sabbath cafe clash lays bare Israel faultlines
-
As machinery removes rubble, hopes for survivors from Colombian quake dwindle
-
Gold Roth IRA: How It Works, Rules, Taxes, Fees, and What Investors Should Know in 2026 (Guide Released)
-
Top-ranked Scheffler powers to PGA St. Jude Championship victory
-
Trump says US scaling back military drills with South Korea
-
Jacquet scores on Liverpool debut in friendly win over Como
-
Zambia's Hichilema takes early lead in reelection bid
-
Hawaii's Big Island begins recovery efforts as Hurricane Lala downgrades, moves west
-
Sabalenka squeezes out a win on sixth match point in Cincinnati
-
Spidey swings high for third weekend in N. American box office
-
Duplantis dominant, Hunt hits four and Asher-Smith makes history
-
Eagle and late birdie lift Jeeno to LPGA Portland Classic win
-
Spanish soldier dies in Aragon wildfire
-
Duplantis masterclass for fourth Euro pole vault title
-
PSG beaten by Lens in French Champions' Trophy
-
Records for Asher-Smith, Hunt as Britain win 4x100m mixed relay
-
Rybakina, Andreeva race into Cincinnati third round
-
Barcelona reach deal with Man City to sign Rodri
-
Amy Hunt bags fourth Euro gold as Britain win 4x100m mixed relay
-
Misery for Maresca as Man City make dismal start to life after Guardiola
-
Spanish soldier dies in Aragon wildfire: regional leader
-
Strikes kill 19 in Russia and Ukraine
-
Belgium's Pocognoli appointed new Scotland manager
-
Lula and Bolsonaro court women voters as Brazil election campaign kicks off
-
Marchand storms to second gold of European championships
-
Belgium races to tame huge wildfire creeping towards Germany
-
Kushner meets with Hamas in push to revive Gaza plan
-
Two dead, hundreds evacuated from fires on island near Athens
-
Villarreal battle back to earn draw at promoted Racing
-
Real Madrid crush Schalke in friendly as Diomande debuts
-
Odegaard says Arsenal 'want to win everything' after Community Shield success
-
Calls for UK inquiry into 'hounding' of ex-Cambridge academic
-
Arsenal rout Man City in Community Shield masterclass
-
Strikes kill 16 in Russia and Ukraine
-
Southampton mocked over Spygate during Watford defeat
-
Marchand tries for European swim gold in unfamiliar event
-
Hamas expects meeting with Kushner as US pushes Gaza plan
-
India's Padikkal steals the show with 167 in first Sri Lanka Test
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
A.Jones--AMWN